| The population pharmacokinetics of R‐ and S‐warfarin: effect of genetic and clinical factors S Lane, S Al‐Zubiedi, E Hatch, I Matthews, AL Jorgensen, P Deloukas, ... British journal of clinical pharmacology 73 (1), 66-76, 2012 | 111 | 2012 |
| Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study AL Jorgensen, S Al-Zubiedi, JE Zhang, A Keniry, A Hanson, DA Hughes, ... Pharmacogenetics and genomics 19 (10), 800-812, 2009 | 86 | 2009 |
| Knowledge, attitudes, and practices of pharmacovigilance and ADRs spontaneous reporting among pediatricians and pediatric residents in Jordan TL Mukattash, MW Alwadi, RK Abu-Farha, AS Jarab, SA Al-Zubiedi, ... Current clinical pharmacology 13 (1), 45-54, 2018 | 12 | 2018 |
| Impact of risk communication on patient’s safety during the pandemic HP Zuluaga-Arias, M Alkhakany, MM Younus, H Sefiani, A Caro-Rojas, ... Therapeutic Advances in Drug Safety 14, 20420986231159752, 2023 | 4 | 2023 |
| Predictors of Anticoagulant Treatment Control in New Warfarin Patients in Jordan B Khatib, H ALSalamat, M Krishan, S Al-Zubiedi Authorea Preprints, 2023 | 1 | 2023 |
| Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic SA Al-Zubiedi, M Younus, S Al-Khalidi, M Ekilo, TM Alshammari Expert Opinion on Drug Safety 22 (2), 165-174, 2023 | 1 | 2023 |
| Analysis of a Cohort of Patients with Atrial Fibrillation on Warfarin: The Jordan Atrial Fibrillation Study (JoFib) TN Al-Shatanawi, O Alkouri, HA ALSalamat, S Al-Zubiedi, OA Qaladi, ... Preprints, 2024 | | 2024 |
| Off-label drug use and Adverse Drug Events (ADEs) in paediatric patients: An analysis of the Jordanian National Pharmacovigilance Database S Al-zubiedi, N Bawaresh DRUG SAFETY 40 (10), 989-990, 2017 | | 2017 |
| PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN: A PROSPECTIVE ANALYSIS DA Hughes, S Al-Zubiedi, A Hanson, A Jorgensen, M Pirmohamed Value in Health 12 (3), A3-A4, 2009 | | 2009 |
| Investigating warfarin variability: the contribution of clinical, genetic, and environmental factors SA Al-Zubiedi PQDT-Global, 2009 | | 2009 |
| The pharmacokinetic profile of Warfarn: a systematic review D Hughes, S Al-Zubiedi, DA Hughes, M Pirmohamed British Pharmacological Society winter meeting, Brighton, UK, 2007 | | 2007 |
| The pharmacokinetic profile of Warfarn: a systematic review S Al-Zubiedi, DA Hughes, M Pirmohamed British Pharmacological Society winter meeting, Brighton, UK, 2007 | | 2007 |
| Population pharmacokinetics of warfarin: Intermin analysis of the Liverpool pharmacogenetic prospective cohort study D Hughes, I Matthews, L Aarons, S Al-Zubiedi, E Hatch, S Lane, ... Pharmacokinetics UK, Edinburgh, Scotland, UK, 2007 | | 2007 |
